Apr 08, 2025 (PRISM News via COMTEX) --
Tilray Inc. (NASDAQ: TLRY) experienced a significant decline in its share price, dropping over 16%, following the release of its fiscal third-quarter financial results, which fell short of investor expectations.
The company’s revenue decreased year-over-year, registering at $185.8 million compared to $188.3 million, notably falling short of the forecasted $209.8 million.
Revenue from cannabis products declined by 14% from the same quarter last year to $54.3 million, whereas sales in beverage alcohol saw a modest increase of 2.3%, reaching $55.9 million.
Tilray reported a substantial net loss of $793.5 million, largely attributed to a non-cash impairment charge of $700 million.
The adjusted earnings per share stood at $0.00, surpassing analysts’ expectations for a loss per share of $0.03.
Analysts from Jefferies acknowledged the revenue shortfall but viewed the company’s emphasis on improving margins as a positive sign, noting that gross margins increased by 61 basis points thanks to an improved product mix and reduced costs.
They characterized the quarter as "mixed" and emphasized that fiscal 2025 remains a pivotal transition period for Tilray.
The firm maintains a 'Buy' rating on Tilray with a price target set at $2.50, suggesting a potential upside of 332% based on current evaluations.
As of early Tuesday afternoon, Tilray’s shares were trading down 16.7% at $0.48.
The post Tilray Stock Declines as Quarterly Revenue Misses Expectations appeared first on PRISM MarketView.
COMTEX_464351009/2927/2025-04-08T14:00:50
